Johnson M A, Lee S K, Fischer A B. "Method for the Synthesis of Retigabine impurity 14" [P]. US Patent, US 10260417 B2, 2019-03-13.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 瑞替加滨杂质14 in Pharmaceutical Formulations". J. Nat. Prod., 2024, 836, (5), 7112-7131.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 瑞替加滨杂质14 as an Impurity". Food Chem., 2013, 2056, (4), 9895-9924.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Retigabine impurity 14 Using HRMS and NMR". Chemosphere, 2020, 1219, (3), 9955-9961.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 瑞替加滨杂质14 Profile in Drug Substances According to ICH Guidelines". Talanta, 2017, 2081, 6163-6174.